{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T02:00:50Z","timestamp":1772244050215,"version":"3.50.1"},"reference-count":48,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2013.0443","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T05:25:18Z","timestamp":1525238718000},"source":"Crossref","is-referenced-by-count":4,"title":["Fluid Replacement With Hydroxyethyl Starch in Critical Care"],"prefix":"10.3238","author":[{"given":"Christiane S.","family":"Hartog","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Welte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Schlattmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konrad","family":"Reinhart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"11437","published-online":{"date-parts":[[2013,6,28]]},"reference":[{"key":"10.3238\/arztebl.2013.0443_ref1","doi-asserted-by":"crossref","unstructured":"Weiser TG, Regenbogen SE, Thompson KD, et al.: An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet 2008; 372: 139\u201344.","DOI":"10.1016\/S0140-6736(08)60878-8"},{"key":"10.3238\/arztebl.2013.0443_ref2","doi-asserted-by":"crossref","unstructured":"Finfer S, Liu B, Taylor C, et al.: Resuscitation fluid use in critically ill adults: an international cross sectional study in 391 intensive care units. Crit Care 2010; 14: R185.","DOI":"10.1186\/cc9293"},{"key":"10.3238\/arztebl.2013.0443_ref3","doi-asserted-by":"crossref","unstructured":"Shaw AD, Kellum JA: The Risk of AKI in Patients Treated with Intravenous Solutions Containing Hydroxyethyl Starch. Clin J Am Soc Nephrol 2013; 8: 497\u2013503.","DOI":"10.2215\/CJN.10921012"},{"key":"10.3238\/arztebl.2013.0443_ref4","doi-asserted-by":"crossref","unstructured":"Perel P, Roberts I, Ker K: Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2013; 2: CD000567.","DOI":"10.1002\/14651858.CD000567.pub6"},{"key":"10.3238\/arztebl.2013.0443_ref5","unstructured":"Hartog CS, Reinhart K: Volumenersatztherapie mit HES. Dtsch Apoth Ztg 2011; 151: 567\u201381."},{"key":"10.3238\/arztebl.2013.0443_ref6","doi-asserted-by":"crossref","unstructured":"Choi PT, Yip G, Quinonez LG, et al.: Crystalloids vs. colloids in fluid resuscitation: a systematic review. Crit Care Med 1999; 27: 200\u201310.","DOI":"10.1097\/00003246-199901000-00053"},{"key":"10.3238\/arztebl.2013.0443_ref7","doi-asserted-by":"crossref","unstructured":"Schierhout G, Roberts I: Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials. BMJ 1998; 316: 961\u20134.","DOI":"10.1136\/bmj.316.7136.961"},{"key":"10.3238\/arztebl.2013.0443_ref8","unstructured":"Alderson P, Bunn F, Lefebvre C, et al.: Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev 2004; 4: CD001208"},{"key":"10.3238\/arztebl.2013.0443_ref9","doi-asserted-by":"crossref","unstructured":"Groeneveld AB, Navickis RJ, Wilkes MM: Update on the comparative safety of colloids: a systematic review of clinical studies. Ann Surg 2011; 253: 470\u201383.","DOI":"10.1097\/SLA.0b013e318202ff00"},{"key":"10.3238\/arztebl.2013.0443_ref10","doi-asserted-by":"crossref","unstructured":"Cittanova ML, Leblanc I, Legendre C, et al.: Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 1996; 348: 1620\u20132.","DOI":"10.1016\/S0140-6736(96)07588-5"},{"key":"10.3238\/arztebl.2013.0443_ref11","doi-asserted-by":"crossref","unstructured":"Schortgen F, Lacherade JC, Bruneel F, et al.: Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 2001; 357: 911\u20136.","DOI":"10.1016\/S0140-6736(00)04211-2"},{"key":"10.3238\/arztebl.2013.0443_ref12","doi-asserted-by":"crossref","unstructured":"Brunkhorst FM, Engel C, Bloos F, et al.: Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358: 125\u201339.","DOI":"10.1056\/NEJMoa070716"},{"key":"10.3238\/arztebl.2013.0443_ref13","doi-asserted-by":"crossref","unstructured":"Westphal M, James MF, Kozek-Langenecker S, et al.: Hydroxyethyl starches: different products\u2014different effects. Anesthesiology 2009; 111: 187\u2013202.","DOI":"10.1097\/ALN.0b013e3181a7ec82"},{"key":"10.3238\/arztebl.2013.0443_ref14","doi-asserted-by":"crossref","unstructured":"Dart AB, Mutter TC, Ruth CA, et al.: Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst Rev 2010; 1: CD007594.","DOI":"10.1002\/14651858.CD007594.pub2"},{"key":"10.3238\/arztebl.2013.0443_ref15","doi-asserted-by":"crossref","unstructured":"Hartog CS, Kohl M, Reinhart K: A systematic review of third-generation hydroxyethyl starch (HES 130\/0.4) in resuscitation: safety not adequately addressed. Anesth Analg 2011; 112: 635\u201345.","DOI":"10.1213\/ANE.0b013e31820ad607"},{"key":"10.3238\/arztebl.2013.0443_ref16","doi-asserted-by":"crossref","unstructured":"Myburgh JA, Finfer S, Bellomo R, et al.: Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012; 367: 1901\u201311.","DOI":"10.1056\/NEJMoa1209759"},{"key":"10.3238\/arztebl.2013.0443_ref17","doi-asserted-by":"crossref","unstructured":"Perner A, Haase N, Guttormsen AB, et al.: Hydroxyethyl starch 130\/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012; 367: 124\u201334.","DOI":"10.1056\/NEJMoa1204242"},{"key":"10.3238\/arztebl.2013.0443_ref18","doi-asserted-by":"crossref","unstructured":"Zarychanski R, Abou-Setta AM, Turgeon AF, et al.: Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis. JAMA 2013; 309: 678\u201388.","DOI":"10.1001\/jama.2013.430"},{"key":"10.3238\/arztebl.2013.0443_ref19","doi-asserted-by":"crossref","unstructured":"Haase N, Perner A, Hennings LI, et al.: Hydroxyethyl starch 130\/0.38\u20130.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis. BMJ 2013; 346: f839. doi: 10.1136\/bmj.f839.","DOI":"10.1136\/bmj.f839"},{"key":"10.3238\/arztebl.2013.0443_ref20","doi-asserted-by":"crossref","unstructured":"Patel A, Waheed U, Brett SJ: Randomised trials of 6 % tetrastarch (hydroxyethyl starch 130\/0.4 or 0.42) for severe sepsis reporting mortality: systematic review and meta-analysis. Intensive Care Med 2013; 39: 811\u201322.","DOI":"10.1007\/s00134-013-2863-6"},{"key":"10.3238\/arztebl.2013.0443_ref21","unstructured":"Solutions for infusion containing hydroxyethyl starch. 2012 Available from: www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/referrals\/Hydroxyethyl_starch-containing_solutions\/human_referral_prac_000012.jsp&mid= WC0b01ac05805c516f. Last accessed on 8th June 2013."},{"key":"10.3238\/arztebl.2013.0443_ref22","unstructured":"Food and Drug Administration (FDA) Public Workshop \u2013 Risks and Benefits of Hydroxyethyl Starch Solutions. September 6, 2012 Available from: www.fda.gov\/BiologicsBloodVaccines\/NewsEvents\/WorkshopsMeetingsConferences\/ucm313370.htm. Last accessed on 8th June 2013."},{"key":"10.3238\/arztebl.2013.0443_ref23","doi-asserted-by":"crossref","unstructured":"Reinhart K, Perner A, Sprung CL, et al.: Consensus statement of the ESICM task force on colloid volume therapy in critically ill patients. Intensive Care Med 2012; 38: 368\u201383.","DOI":"10.1007\/s00134-012-2472-9"},{"key":"10.3238\/arztebl.2013.0443_ref24","unstructured":"R Core Team: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing. www.R-project.org\/. Last accessed on 1st March 2013."},{"key":"10.3238\/arztebl.2013.0443_ref25","unstructured":"Schwarzer G. meta: Meta-analysis with R. R package version 2.1\u20132. 2012. http:\/\/CRAN.R-project.org\/package=meta. Last accessed on 1st March 2013."},{"key":"10.3238\/arztebl.2013.0443_ref26","doi-asserted-by":"crossref","unstructured":"James MF, Michell WL, Joubert IA, et al.: Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma). Br J Anaesth 2011; 107: 693\u2013702.","DOI":"10.1093\/bja\/aer229"},{"key":"10.3238\/arztebl.2013.0443_ref27","doi-asserted-by":"crossref","unstructured":"Guidet B, Martinet O, Boulain T, et al.: Assessment of hemodynamic efficacy and safety of 6 % hydroxyethylstarch 130\/0.4 versus 0.9 % NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study. Critical Care 2012; 16: R94.","DOI":"10.1186\/cc11358"},{"key":"10.3238\/arztebl.2013.0443_ref28","unstructured":"Dolecek M, Svoboda P, Kantorova I, et al.: Therapeutic influence of 20 % albumin versus 6 % hydroxyethylstarch on extravascular lung water in septic patients: a randomized controlled trial. Hepatogastroenterology 2009; 56: 1622\u20138."},{"key":"10.3238\/arztebl.2013.0443_ref29","doi-asserted-by":"crossref","unstructured":"Dubin A, Pozo MO, Casabella CA, et al.: Comparison of 6 % hydroxyethyl starch 130\/0.4 and saline solution for resuscitation of the microcirculation during the early goal-directed therapy of septic patients. J Crit Care 2010; 25: 659. e651\u20138.","DOI":"10.1016\/j.jcrc.2010.04.007"},{"key":"10.3238\/arztebl.2013.0443_ref30","unstructured":"Palumbo D, Servillo G, D'Amato L, et al.: The effects of hydroxyethyl starch solution in critically ill patients. Minerva Anestesiol 2006; 72: 655\u201364."},{"key":"10.3238\/arztebl.2013.0443_ref31","doi-asserted-by":"crossref","unstructured":"Kellum JA, Bellomo R, Ronco C: The concept of acute kidney injury and the RIFLE criteria. Contrib Nephrol 2007; 156: 10\u20136.","DOI":"10.1159\/000102010"},{"key":"10.3238\/arztebl.2013.0443_ref32","doi-asserted-by":"crossref","unstructured":"Gattas DJ, Dan A, Myburgh J, et al.: Fluid resuscitation with 6 % hydroxyethyl starch (130\/0.4 and 130\/0.42) in acutely ill patients: systematic review of effects on mortality and treatment with renal replacement therapy. Intensive Care Med 2013; 39: 558\u201368.","DOI":"10.1007\/s00134-013-2840-0"},{"key":"10.3238\/arztebl.2013.0443_ref33","doi-asserted-by":"crossref","unstructured":"Bayer O, Reinhart K, Kohl M, et al.: Effects of fluid resuscitation with synthetic colloids or crystalloids alone on shock reversal, fluid balance, and patient outcomes in patients with severe sepsis: A prospective sequential analysis. Crit Care Med 2012; 40: 2543\u201351.","DOI":"10.1097\/CCM.0b013e318258fee7"},{"key":"10.3238\/arztebl.2013.0443_ref34","doi-asserted-by":"crossref","unstructured":"Schick MA, Isbary TJ, Schlegel N, et al.: The impact of crystalloid and colloid infusion on the kidney in rodent sepsis. Intensive Care Med 2010; 36: 541\u20138.","DOI":"10.1007\/s00134-009-1704-0"},{"key":"10.3238\/arztebl.2013.0443_ref35","doi-asserted-by":"crossref","unstructured":"van Der Linden P, James M, Mythen M, et al.: Review article: safety of modern starches used during surgery. Anesth Analg 2013; 116: 35\u201348.","DOI":"10.1213\/ANE.0b013e31827175da"},{"key":"10.3238\/arztebl.2013.0443_ref36","doi-asserted-by":"crossref","unstructured":"Martin C, Jacob M, Vicaut E, et al.: Effect of waxy maize-derived hydroxyethyl starch 130\/0.4 on renal function in surgical patients. Anesthesiology 2013; 118: 387\u201394.","DOI":"10.1097\/ALN.0b013e31827e5569"},{"key":"10.3238\/arztebl.2013.0443_ref37","doi-asserted-by":"crossref","unstructured":"Hartog CS, Takala J, Reinhart K: Safety of modern starches used during surgery\u2014misleading conclusions. Anesth Analg 2013; [in press].","DOI":"10.1213\/ANE.0b013e318296913f"},{"key":"10.3238\/arztebl.2013.0443_ref38","doi-asserted-by":"crossref","unstructured":"Natanson C, Kern SJ, Lurie P, et al.: Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis. JAMA 2008; 299: 2304\u201312.","DOI":"10.1001\/jama.299.19.jrv80007"},{"key":"10.3238\/arztebl.2013.0443_ref39","doi-asserted-by":"crossref","unstructured":"Feldheiser A, Pavlova V, Bonomo T, et al.: Balanced crystalloid compared with balanced colloid solution using a goal-directed haemodynamic algorithm. Br J Anaesth 2013; 110: 231\u201340.","DOI":"10.1093\/bja\/aes377"},{"key":"10.3238\/arztebl.2013.0443_ref40","doi-asserted-by":"crossref","unstructured":"Bayer O, Reinhart K, Hartog C, et al.: Peri-operative fluid therapy with tetrastarch and gelatin in cardiac surgery\u2014a prospective sequential analysis. Crit Care Med 2013; [in press].","DOI":"10.1097\/CCM.0b013e3182978fb6"},{"key":"10.3238\/arztebl.2013.0443_ref41","doi-asserted-by":"crossref","unstructured":"James MFM, Michell WL, Joubert IA, et al.: Re: Hydroxyethyl starch in patients with trauma, author's reply. In: Br J Anaesth 2012; 108: 322\u20134.","DOI":"10.1093\/bja\/aer463"},{"key":"10.3238\/arztebl.2013.0443_ref42","doi-asserted-by":"crossref","unstructured":"Evidence-based colloid use in the critically ill: American Thoracic Society Consensus Statement. Am J Respir Crit Care Med 2004; 170: 1247\u201359.","DOI":"10.1164\/rccm.200208-909ST"},{"key":"10.3238\/arztebl.2013.0443_ref43","doi-asserted-by":"crossref","unstructured":"Dellinger RP, Levy MM, Rhodes A, et al.: Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013; 39: 165\u2013228.","DOI":"10.1007\/s00134-012-2769-8"},{"key":"10.3238\/arztebl.2013.0443_ref44","unstructured":"National Institute for Health and Care Excellence (NICE): Colloids versus crystalloids for fluid resuscitation in critically ill patients. In: QIPP (Quality, Innovation, Productivity and Prevention)\u2014NHS Evidence. The UK Cochrane Centre and NICE 2011; www.evidence.nhs.uk\/search?q=colloids&am=[{%22srn%22%3A[%22%20 qipp%20%22]}]&fs=qippcat.Category_CochraneQIPP.Last accessed on 8th June 2013."},{"key":"10.3238\/arztebl.2013.0443_ref45","doi-asserted-by":"crossref","unstructured":"Hartog CS, Reuter D, Loesche W, et al.: Influence of hydroxyethyl starch (HES) 130\/0.4 on hemostasis as measured by viscoelastic device analysis: a systematic review. Intensive Care Med 2011; 37: 1725\u201337.","DOI":"10.1007\/s00134-011-2385-z"},{"key":"10.3238\/arztebl.2013.0443_ref46","doi-asserted-by":"crossref","unstructured":"Bellmann R, Feistritzer C, Wiedermann CJ: Effect of molecular weight and substitution on tissue uptake of hydroxyethyl starch: a meta-analysis of clinical studies. Clin Pharmacokinet 2012; 51: 225\u201336.","DOI":"10.2165\/11594700-000000000-00000"},{"key":"10.3238\/arztebl.2013.0443_ref47","unstructured":"US Department of Health and Human Services, Public Health Service, Food and Drug Administration (FDA): NDA REVIEW MEMO (MID-CYCLE). www.fda.gov\/downloads\/BiologicsBloodVaccines\/BloodBloodProducts\/ApprovedProducts\/NewDrugApplicationsNDAs\/UCM083393.pdf. Last accessed on 20 November 2010."},{"key":"10.3238\/arztebl.2013.0443_ref48","doi-asserted-by":"crossref","unstructured":"Wiedermann C, Joannidis M: Increased mortality after infusion of \u201cmodern\u201d hydroxyethyl starch. Swiss Med Wkly 2013; 143: w13747.","DOI":"10.4414\/smw.2013.13747"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2013.0443","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T08:51:01Z","timestamp":1638780661000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2013.0443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,28]]},"references-count":48,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2013.0443","relation":{"is-cited-by":[{"id-type":"doi","id":"10.1155\/2015\/307230","asserted-by":"object"}]},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,28]]}}}